Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype |hepatitis
Sentences 268
PubMedID- 21480326 Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis b virus (hbv) infection.
PubMedID- 21548981 hepatocellular carcinoma is mainly associated with viral hepatitis b and c.
PubMedID- 21196168 Immunization practices and the use of potent antiviral therapy may have a major impact in reducing the burden of chronic liver disease and the incidence of hepatocellular carcinoma associated with chronic hepatitis b and chronic hepatitis d.
PubMedID- 25912838 We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis.
PubMedID- 25803433 Tsan et al used this definition to study statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection [24].
PubMedID- 25521761 Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (hcc) related with hepatitis b-viral infection.
PubMedID- 26519622 The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis.
PubMedID- 26350363 Background: hepatocellular carcinoma (hcc) not associated with active hepatitis b virus (hbv) or hepatitis c virus (hcv) infection, termed non-b non-c hcc (nbnc-hcc), is reportedly correlated with better survival outcomes than hbv- or hcv-related hcc.
PubMedID- 26264553 Circulating micrornas as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 20495329 [a case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of uft-e].
PubMedID- 22212935 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 23098451 Why is hepatocellular carcinoma less attributable to viral hepatitis in yemen.
PubMedID- 22096937 [antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis].
PubMedID- 21056500 The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
PubMedID- 23426277 Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c.
PubMedID- 25650331 Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 26070204 Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response.
PubMedID- 24409059 Aim: to study the potential association between hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc), cirrhosis and latent hepatitis b (lhb) infection, defined as the absence of detectable serum hepatitis b surface antigen (hbsag) and the presence of hepatitis b core antibody (hbcab).
PubMedID- 24367218 Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus.
PubMedID- 21858035 Patients had no other causes of liver disease, autoimmune or metabolic disorders, hepatocellular carcinoma and coinfection with hepatitis b virus and/or human immunodeficiency virus.
PubMedID- 24020023 Indications for living-donor liver transplantation in these patients were hepatitis b cirrhosis with hepatocellular carcinoma (n = 8), hepatitis b cirrhosis without hepatocellular carcinoma (n = 3), autoimmune disease (n = 1), and wilson's disease (n = 2).
PubMedID- 25082726 Although the development of hepatocellular carcinoma following infection with hepatitis virus is a crucial health problem, there are few reports of hemophilia patients undergoing liver resection for hepatocellular carcinoma.
PubMedID- 22659345 Polymorphisms of dna repair genes in korean hepatocellular carcinoma patients with chronic hepatitis b: possible implications on survival.
PubMedID- 23509319 Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 25312649 The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy.
PubMedID- 23657093 Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death [2].
PubMedID- 24312130 To investigate whether killer cell immunoglobulin-like receptor (kir) and human leukocyte antigen (hla) genetic background could influence the onset age of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection, one hundred and seventy-one males with hbv-related hcc were enrolled.
PubMedID- 23895367 Hepaticus, the cause of chronic typhlocolitis and hepatitis leading to colonic and hepatocellular carcinomas in mice.
PubMedID- 25921128 Cyp2c19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis b infection in thailand.
PubMedID- 21104161 Association of novel mutations and haplotypes in the pres region of hepatitis b virus with hepatocellular carcinoma.
PubMedID- 22695885 Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis.
PubMedID- 24614696 Alpha-fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis b selected for liver transplantation.
PubMedID- 24696192 Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis b virus dna levels and high preoperative hepatitis b surface antigen levels.
PubMedID- 24223741 Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir).
PubMedID- 23701091 Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis.
PubMedID- 21526141 We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance.
PubMedID- 25894298 Aflatoxin levels in chronic hepatitis b patients with cirrhosis or hepatocellular carcinoma in balikesir, turkey.
PubMedID- 25657603 In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis.
PubMedID- 24405714 [41] showed that the expression level of mir-122 continues to decrease in hepatocellular carcinoma with chronic hepatitis b viral infection compared with preoperative and healthy people.
PubMedID- 25788045 Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment.
PubMedID- 24128413 Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis b.
PubMedID- 21910010 Aim: to compare clinical and radiological findings of newly diagnosed hepatocellular carcinomas (hccs) in patients with chronic hepatitis b virus (hbv) and chronic hepatitis c virus (hcv) infections.
PubMedID- 24918150 Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis b.
PubMedID- 24703510 Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection.
PubMedID- 22427959 Helicobacter hepaticus (h. hepaticus), another enteric pathogen known to induce spontaneous, chronic colitis in certain susceptible mouse strains, is also associated with active chronic hepatitis and development of hepatocellular carcinoma in both inbred and knockout strains of mice [42], [43], [44].
PubMedID- 23602201 High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 20951214 Furthermore, research has suggested that its activity is up-regulated in hepatitis-c-virus-infected patients with hepatocellular carcinoma.
PubMedID- 23641353 There were three patients with hepatitis b virus infection of the hepatocellular carcinoma (n=5), but no patients with a positive antihepatitis c virus antibody.
PubMedID- 23125843 The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005).
PubMedID- 22946841 The objective of the present study was to explore the common and specific metabolic alterations of hepatocellular carcinoma (hcc) infected with hepatitis b virus (hbv) or hepatitis c virus (hcv).

Page: 1 2 3 4 5 6